TickerFactsScreenerDevelopers

Coherus Oncology, Inc. (CHRS) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$97.08M2014: $66.80M2015: -$6.21M2016: $20.53M2017: $30.54M2018: -$38.59M2019: $105.21M2020: $280.97M2021: $97.73M2022: -$137.42M2023: -$193.43M2024: -$131.99M2025: $61.01M$61.01M
2013Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$61.01M+146.2%
2024-$131.99M+31.8%
2023-$193.43M-40.8%
2022-$137.42M-240.6%
2021$97.73M-65.2%
2020$280.97M+167.1%
2019$105.21M+372.6%
2018-$38.59M-226.4%
2017$30.54M+48.8%
2016$20.53M+430.7%
2015-$6.21M-109.3%
2014$66.80M+168.8%
2013-$97.08M—